Marinomed Biotech Dividends and Buybacks
Dividend criteria checks 0/6
Marinomed Biotech does not have a record of paying a dividend.
Key information
n/a
Dividend yield
0.3%
Buyback Yield
| Total Shareholder Yield | 0.3% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
A Look At The Fair Value Of Marinomed Biotech AG (VIE:MARI)
May 25
Marinomed Biotech AG (VIE:MARI) Could Be Riskier Than It Looks
Feb 03Marinomed Biotech AG (VIE:MARI) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Apr 22Marinomed Biotech AG's (VIE:MARI) Analyst Just Slashed This Year's Estimates
Sep 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if MARI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MARI's dividend payments have been increasing.
Dividend Yield vs Market
| Marinomed Biotech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (MARI) | n/a |
| Market Bottom 25% (AT) | 2.2% |
| Market Top 25% (AT) | 6.1% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast (MARI) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate MARI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MARI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate MARI's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as MARI has not reported any payouts.